tocilizumab
Disappointing Results From First Phase 3 Trial of Tocilizumab for COVID-19
Genentech reported that its phase 3 COVACTA study of tocilizumab in hospitalized adults with severe ...
JULY 30, 2020
BTK Inhibitors, Other Blood Cancer Drugs Are Being Tapped for COVID-19
Studies are underway exploring immunomodulating agents approved for hematologic malignancies in the treatment of ...
JULY 23, 2020
FDA Approves Actemra for Treatment of CAR T-Cell–Induced CRS
Tocilizumab (Actemra, Genentech) has received an additional indication—treatment of chimeric antigen receptor ...
AUGUST 31, 2017
Load more